Balchem Corporation (BCPC)
| Bid | 116.11 |
| Market Cap | 5.25B |
| Revenue (ttm) | 953.68M |
| Net Income (ttm) | 128.47M |
| EPS (ttm) | 3.94 |
| PE Ratio (ttm) | 40.98 |
| Forward PE | 31.72 |
| Analyst | Buy |
| Ask | 171 |
| Volume | 110,027 |
| Avg. Volume (20D) | 171,245 |
| Open | 161.41 |
| Previous Close | 161.31 |
| Day's Range | 160.78 - 162.48 |
| 52-Week Range | 137.69 - 186.03 |
| Beta | 0.75 |
About BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the...
Analyst Forecast
According to 1 analyst ratings, the average rating for BCPC stock is "Buy." The 12-month stock price forecast is $190, which is an increase of 17.67% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Balchem Is A Great Company, But I'm Still Waiting For A Better EntryBalchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw mode...
1 month ago · seekingalpha.com
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call TranscriptBalchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call P...
